Importantly, considering these complexities regarding AIM2 biological functions in gastrointestinal pathologies, future studies are warranted to couple conditional knockout strains of AIM2 with gastrointestinal disease models (including Helicobacter infection) to identify specific AIM2‐expressing cell types that modulate disease pathogenesis. This evidence concerns the gene AIM2 and Helicobacter pylori infectious disease.